Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. Upon a suggestion by the European Association of Pharma Biotechnology (EAPB), pharmaceutical biotechnology is defined as a science covering all technologies required for the production, manufacturing, and registration of biotechnological drugs. The biopharmaceutical industry has changed dramatically since the first recombinant protein (Humulin) was approved for marketing in 1982. The range of resources required for the pharmaceutical industry has expanded from its traditional fields. Advances in the field of recombinant genetics allows scientists to routinely clone genes and create genetically modified organisms that can be used in industrial production processes. Also, specific therapeutic proteins can be synthesized in no biological ways.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. Upon a suggestion by the European Association of Pharma Biotechnology (EAPB), pharmaceutical biotechnology is defined as a science covering all technologies required for the production, manufacturing, and registration of biotechnological drugs. The biopharmaceutical industry has changed dramatically since the first recombinant protein (Humulin) was approved for marketing in 1982. The range of resources required for the pharmaceutical industry has expanded from its traditional fields. Advances in the field of recombinant genetics allows scientists to routinely clone genes and create genetically modified organisms that can be used in industrial production processes. Also, specific therapeutic proteins can be synthesized in no biological ways.
Mr.D. Manimaran is pursuing PhD (Full Time) in Biotechnology, Periyar University, Salem. He has obtained two Master degrees in Biotechnology and Library and Information Science and PGDCA and Diploma in Medical. He has published good number of research journal articles in International level. He has published seven Books.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. Upon a suggestion by the European Association of Pharma Biotechnology (EAPB), pharmaceutical biotechnology is defined as a science covering all technologies required for the production, manufacturing, and registration of biotechnological drugs. The biopharmaceutical industry has changed dramatically since the first recombinant protein (Humulin) was approved for marketing in 1982. The range of resources required for the pharmaceutical industry has expanded from its traditional fields. Advances in the field of recombinant genetics allows scientists to routinely clone genes and create genetically modified organisms that can be used in industrial production processes. Also, specific therapeutic proteins can be synthesized in no biological ways. 316 pp. Englisch. N° de réf. du vendeur 9783330332966
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Manimaran DharmarMr.D. Manimaran is pursuing PhD (Full Time) in Biotechnology, Periyar University, Salem. He has obtained two Master degrees in Biotechnology and Library and Information Science and PGDCA and Diploma in Medical. He ha. N° de réf. du vendeur 154744512
Quantité disponible : Plus de 20 disponibles
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Pharmaceutical Biotechnology | Dharmar Manimaran (u. a.) | Taschenbuch | 316 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330332966 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 109422372
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. Upon a suggestion by the European Association of Pharma Biotechnology (EAPB), pharmaceutical biotechnology is defined as a science covering all technologies required for the production, manufacturing, and registration of biotechnological drugs. The biopharmaceutical industry has changed dramatically since the first recombinant protein (Humulin) was approved for marketing in 1982. The range of resources required for the pharmaceutical industry has expanded from its traditional fields. Advances in the field of recombinant genetics allows scientists to routinely clone genes and create genetically modified organisms that can be used in industrial production processes. Also, specific therapeutic proteins can be synthesized in no biological ways.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 316 pp. Englisch. N° de réf. du vendeur 9783330332966
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmaceutical biotechnology has a long tradition and is rooted in the last century, first exemplified by penicillin and streptomycin as low molecular weight biosynthetic compounds. Today, pharmaceutical biotechnology still has its fundamentals in fermentation and bioprocessing, but the paradigmatic change affected by biotechnology and pharmaceutical sciences has led to an updated definition. Upon a suggestion by the European Association of Pharma Biotechnology (EAPB), pharmaceutical biotechnology is defined as a science covering all technologies required for the production, manufacturing, and registration of biotechnological drugs. The biopharmaceutical industry has changed dramatically since the first recombinant protein (Humulin) was approved for marketing in 1982. The range of resources required for the pharmaceutical industry has expanded from its traditional fields. Advances in the field of recombinant genetics allows scientists to routinely clone genes and create genetically modified organisms that can be used in industrial production processes. Also, specific therapeutic proteins can be synthesized in no biological ways. N° de réf. du vendeur 9783330332966
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 316 pages. 8.66x5.91x0.72 inches. In Stock. N° de réf. du vendeur 3330332964
Quantité disponible : 1 disponible(s)